ホーム>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>D-Sedoheptulose 7-phosphate

D-Sedoheptulose 7-phosphate

カタログ番号GC61494

D-セドヘプツロース 7-リン酸は、セプタシジン (グループ III) およびハイグロマイシン B (グループ IV) のヘプトースの一般的な前駆体です。

Products are for research use only. Not for human use. We do not sell to patients.

D-Sedoheptulose 7-phosphate 化学構造

Cas No.: 2646-35-7

サイズ 価格 在庫数 個数
5 mg
$1,530.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

D-Sedoheptulose 7-phosphate is a common precursor for the heptoses of septacidin (group III) and hygromycin B (group IV). D-Sedoheptulose 7-phosphate can be converted to NDP-heptoses through similar biosynthetic pathways in those compounds [1].

Sedoheptulose 7-phosphate can be converted to ADP-l-glycero-β-d-manno-heptose by SepB, SepL, and SepC, it involves in ADP-sugar in microbial natural product biosynthesis[1].SepB is an S-7-P isomerase, SepL involves in the biosynthesis of heptoses of the core region of E. coli LPS, and they catalyze a four-reaction relay converting S-7-P into ADP-d-glycero-β-d-manno-heptose [1].Septacidin and its analogs are potential anticancer and pain-relief agents[1].Hygromycin B is an anthelmintic agent practically used in swine and poultry farming[1].

[1]. Tang W, et al. d-Sedoheptulose-7-phosphate is a common precursor for the heptoses of septacidin and hygromycin B.Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2818-2823.

レビュー

Review for D-Sedoheptulose 7-phosphate

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-Sedoheptulose 7-phosphate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.